申请人:Alihodzic Sulejman
公开号:US20110281812A1
公开(公告)日:2011-11-17
2′-O-substituted 14- or 15-membered azalide macrolides of Formula (I)
wherein R
6
represents
(i) —C
1-8
alkyl, unsubstituted or substituted at the terminal carbon atom by a group selected from hydroxy, —C
1-3
alkoxy and —C(O)OC
1-3
alkyl, or when
—C
1-8
alkyl is branched, substitution can alternatively be by a hydroxyl group at each of two terminal carbon atoms,
(ii) —CH(NH
2
)C
1-4
alkyl, wherein the —C
1-4
alkyl group may be optionally interrupted by a heteroatom selected from O, S and N,
(iii) —CH
2
N(R
7
)(R
8
), wherein R
7
and R
8
each independently represent H or
—C
1-3
alkyl provided that R
7
and R
8
cannot both simultaneously represent H,
(iv) a 4-6-membered heterocyclic ring containing up to 2 heteroatoms independently selected from O, S and N, wherein the heterocyclic ring is unsubstituted or substituted by —C
1-3
alkyl,
(v) 5-6 membered heteroaromatic ring, unsubstituted or substituted by one to three groups independently selected from halo, hydroxyl, —C
1-3
alkyl, —C
1-3
alkoxy, —CF
3
, —OCF
3
and —NH
2
,
(vi) —CH(NH
2
)CH
2
-aryl wherein the aryl group may be unsubstituted or substituted by one or two substituents independently selected from —C
1-3
alkyl, —C
1-3
alkoxy and hydroxyl,
(vii) —C
3-7
cycloalkyl, or
(viii) phenyl unsubstituted or substituted by one or two groups independently selected from halo, hydroxyl, —C
1-3
alkyl, —C
1-3
alkoxy, —CF
3
, —OCF
3
and —NH
2
,
or salts thereof, useful in the treatment of neutrophil dominated inflammatory diseases, especially in the treatment of neutrophil dominated inflammatory diseases resulting from neutrophilic infiltration and/or diseases associated with altered cellular functionality of neutrophils, to methods for their preparation, to their use as therapeutic agents, and to salts thereof.